FDA to Hold Meeting on Pharmaceutical Product Identifiers Under Drug Supply Chain Law

The Food and Drug Administration will hold a public meeting Oct. 14 in Silver Spring, Maryland, to discuss progress toward implementation of product identification requirements of the Drug Supply Chain Security Act, it said (here). At the meeting, members of the pharmaceutical supply chain may “share information with FDA about the efforts underway to implement” the requirements, “including the use of product identifiers to enhance tracing at the product level,” FDA said. Comments related to the meeting are due Nov. 14.